Table 3.
Clinical characteristics of TEVAR group and MM group.
| Category | MM | TEVAR | P value |
|---|---|---|---|
| Number of patients | 50 | 12 | |
| Male gender | 33 (66.0) | 7 (58.3) | 0.513 |
| Age, years | 63.7 ± 12.7 | 61.0 ± 15.1 | 0.527 |
| Risk factors | |||
| Hypertension | 48 (96.0) | 10 (83.3) | 0.166 |
| Diabetes mellitus | 2 (4.0) | 2 (16.7) | 0.166 |
| Dyslipidemia | 6 (12.0) | 8 (66.7) | <0.001 |
| History of smoking | 17 (34.0) | 6 (50.0) | 0.485 |
| Coronary heart disease | 3 (6.0) | 2 (16.7) | 0.246 |
| Pulmonary disease | 2 (4.0) | 1 (8.3) | 0.482 |
| Renal insufficiency, eGFR < 60 ml/min/1.73 m2 | 1 (2.0) | 1 (8.3) | 0.352 |
| Chronicity classificationa | |||
| Hyperacute | 19 (38.0) | 6 (50.0) | 0.665 |
| Acute | 13 (26.0) | 6 (50.0) | 0.204 |
| Subacute | 18 (36.0) | 0 (0) | 0.035 |
| Chronic | 0 (0) | 0 (0) | / |
| Initial symptom | |||
| Chest and back pain | 35 (70.0) | 10 (83.3) | 0.569 |
| Abdominal pain | 13 (26.0) | 1 (8.3) | 0.352 |
| Loss of consciousness | 0 (0) | 1 (8.3) | 0.194 |
| Dyspnea | 1 (2.0) | 0 (0) | 1.000 |
| Other | 1 (2.0) | 0 (0) | 1.000 |
| Hemodynamics on admission | |||
| SBP, mm Hg | 139.2 ± 38.4 | 145.4 ± 36.9 | 0.076 |
| DBP, mm Hg | 89.4 ± 21.5 | 95.4 ± 19.7 | 0.102 |
| Heart rate | 88.1 ± 17.3 | 93 ± 18.0 | 0.213 |
| In-hospital complications | |||
| Pulmonary infection | 2 (4.0) | 1 (8.3) | 0.482 |
| MI | 1 (2.0) | 0 (0) | 1.000 |
| Stroke | 1 (2.0) | 0 (0) | 1.000 |
| Cardiac tamponade | 1 (2.0) | 0 (0) | 1.000 |
| Aortic rupture | 3 (6.0) | 0 (0) | 1.000 |
| In-hospital mortality | 5 (10.0) | 0 (0) | 0.573 |
| One-year mortality | 6 (12.0) | 1 (8.3) | 1.000 |
DBP, diastolic blood pressure; MM, medical management; SBP, systolic blood pressure; TEVAR, thoracic endovascular aortic repair.
Categorical variables are presented as number (%). Continuous variables are presented as mean ± standard deviation.